Annual Accounts Payable
$40.68 M
+$2.07 M+5.37%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual accounts payable is $40.68 million, with the most recent change of +$2.07 million (+5.37%) on December 31, 2023.
- During the last 3 years, AXSM annual accounts payable has risen by +$27.18 million (+201.24%).
- AXSM annual accounts payable is now at all-time high.
Performance
AXSM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$64.25 M
+$2.91 M+4.75%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly accounts payable is $64.25 million, with the most recent change of +$2.91 million (+4.75%) on September 30, 2024.
- Over the past year, AXSM quarterly accounts payable has increased by +$23.57 million (+57.95%).
- AXSM quarterly accounts payable is now at all-time high.
Performance
AXSM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AXSM Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.4% | +58.0% |
| 3 y3 years | +201.2% | +380.2% |
| 5 y5 years | +1003.3% | +580.1% |
AXSM Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +209.4% | at high | +410.1% |
| 5 y | 5-year | at high | +271.7% | at high | +586.2% |
| alltime | all time | at high | >+9999.0% | at high | +8374.4% |
Axsome Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $64.25 M(+4.7%) |
| Jun 2024 | - | $61.34 M(+14.0%) |
| Mar 2024 | - | $53.79 M(+32.2%) |
| Dec 2023 | $40.68 M(+5.4%) | $40.68 M(+39.8%) |
| Sep 2023 | - | $29.10 M(-32.3%) |
| Jun 2023 | - | $42.96 M(+20.1%) |
| Mar 2023 | - | $35.77 M(-7.3%) |
| Dec 2022 | $38.60 M(+193.6%) | $38.60 M(+200.6%) |
| Sep 2022 | - | $12.84 M(-33.9%) |
| Jun 2022 | - | $19.43 M(+54.3%) |
| Mar 2022 | - | $12.60 M(-4.2%) |
| Dec 2021 | $13.15 M(-2.6%) | $13.15 M(-1.7%) |
| Sep 2021 | - | $13.38 M(+15.2%) |
| Jun 2021 | - | $11.61 M(-20.6%) |
| Mar 2021 | - | $14.62 M(+8.3%) |
| Dec 2020 | $13.50 M(+23.4%) | $13.50 M(+19.3%) |
| Sep 2020 | - | $11.32 M(+20.8%) |
| Jun 2020 | - | $9.36 M(-23.2%) |
| Mar 2020 | - | $12.19 M(+11.4%) |
| Dec 2019 | $10.94 M | $10.94 M(+15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $9.45 M(+53.9%) |
| Jun 2019 | - | $6.14 M(+78.7%) |
| Mar 2019 | - | $3.43 M(-6.9%) |
| Dec 2018 | $3.69 M(+7.3%) | $3.69 M(-11.5%) |
| Sep 2018 | - | $4.17 M(+31.2%) |
| Jun 2018 | - | $3.18 M(-18.1%) |
| Mar 2018 | - | $3.87 M(+12.8%) |
| Dec 2017 | $3.44 M(-15.8%) | $3.44 M(+16.7%) |
| Sep 2017 | - | $2.94 M(-27.1%) |
| Jun 2017 | - | $4.04 M(-14.8%) |
| Mar 2017 | - | $4.74 M(+16.2%) |
| Dec 2016 | $4.08 M(+115.7%) | $4.08 M(+5.5%) |
| Sep 2016 | - | $3.87 M(+27.4%) |
| Jun 2016 | - | $3.04 M(+65.8%) |
| Mar 2016 | - | $1.83 M(-3.3%) |
| Dec 2015 | $1.89 M(+149.6%) | $1.89 M(+10.3%) |
| Sep 2015 | - | $1.72 M(+59.7%) |
| Jun 2015 | - | $1.07 M(+41.7%) |
| Dec 2014 | $758.20 K(+376.0%) | $758.20 K |
| Dec 2013 | $159.30 K | - |
FAQ
- What is Axsome Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Axsome Therapeutics?
- What is Axsome Therapeutics annual accounts payable year-on-year change?
- What is Axsome Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly accounts payable year-on-year change?
What is Axsome Therapeutics annual accounts payable?
The current annual accounts payable of AXSM is $40.68 M
What is the all time high annual accounts payable for Axsome Therapeutics?
Axsome Therapeutics all-time high annual accounts payable is $40.68 M
What is Axsome Therapeutics annual accounts payable year-on-year change?
Over the past year, AXSM annual accounts payable has changed by +$2.07 M (+5.37%)
What is Axsome Therapeutics quarterly accounts payable?
The current quarterly accounts payable of AXSM is $64.25 M
What is the all time high quarterly accounts payable for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly accounts payable is $64.25 M
What is Axsome Therapeutics quarterly accounts payable year-on-year change?
Over the past year, AXSM quarterly accounts payable has changed by +$23.57 M (+57.95%)